FDA Approved: NARATRIPTAN — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approves Bionpharma's Naratriptan as a generic treatment for acute migraine (with or without aura).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• Naratriptan (Naratriptan)

Snippet

ORIG AP for NARATRIPTAN (NARATRIPTAN)